Non-small cell lung carcinoma: understanding cancer microenvironment to drive immunotherapy and patients’ selection

Lung cancer is still the first cause of cancer-related death worldwide with non-small cell lung carcinoma (NSCLC) determining approximately 85% of all cases (1). Almost half of lung cancers present with metastases at the diagnosis.